Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study

Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study

(1) Background: Triple negative breast cancer (TNBC) is a highly aggressive tumor, associated with high rates of early distant recurrence and short survival times, and treatment may require surgery, and thus anesthesia. The effects of anesthetic drugs on cancer progression are under scrutiny, but pu...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Crina E. Tiron, Emilia Patrașcanu, Paula A. Postu, Irina C. Vacarean Trandafir, Adrian Tiron, Ioana Grigoras
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2021-06-01
Schriftenreihe:Current Issues in Molecular Biology
Schlagworte:
AKT
breast cancer
EMT
HIF
sevoflurane
vimentin
Online Zugang:https://www.mdpi.com/1467-3045/43/1/22

Ähnliche Einträge

Ähnliche Einträge